US Stock MarketDetailed Quotes

PRLD Prelude Therapeutics

Watchlist
  • 0.661
  • -0.009-1.34%
Close Mar 11 16:00 ET
36.46MMarket Cap-0.39P/E (TTM)

Prelude Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
7M
4M
3M
0
0
0
0
0
0
0
Operating revenue
--7M
--4M
--3M
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
10.91%146.71M
1.21%37.83M
11.95%37.38M
14.71%37.16M
17.96%34.34M
7.07%132.28M
11.96%37.38M
9.80%33.39M
9.97%32.4M
-3.87%29.12M
Selling and administrative expenses
-0.57%28.72M
-11.86%6.21M
11.16%7.92M
3.00%7.66M
-4.77%6.93M
-5.76%28.88M
-6.24%7.05M
-5.23%7.12M
-8.82%7.43M
-2.49%7.28M
-General and administrative expense
-0.57%28.72M
-11.86%6.21M
11.16%7.92M
3.00%7.66M
-4.77%6.93M
-5.76%28.88M
-6.24%7.05M
-5.23%7.12M
-8.82%7.43M
-2.49%7.28M
Research and development costs
14.12%118M
4.25%31.62M
12.17%29.46M
18.20%29.51M
25.53%27.41M
11.31%103.39M
17.25%30.33M
14.73%26.26M
17.16%24.97M
-4.32%21.83M
Operating profit
-5.62%-139.71M
9.49%-33.83M
-2.97%-34.38M
-14.71%-37.16M
-17.96%-34.34M
-7.07%-132.28M
-11.96%-37.38M
-9.80%-33.39M
-9.97%-32.4M
3.87%-29.12M
Net non-operating interest income expense
Other net income (expense)
20.07%12.54M
18.49%5.1M
-24.20%2.11M
23.23%2.42M
108.45%2.91M
28.92%10.45M
-9.27%4.3M
519.87%2.78M
-5.75%1.97M
69.74%1.4M
Other non- operating income (expenses)
20.07%12.54M
18.49%5.1M
-24.20%2.11M
23.23%2.42M
108.45%2.91M
28.92%10.45M
-9.27%4.3M
519.87%2.78M
-5.75%1.97M
69.74%1.4M
Income before tax
-4.38%-127.17M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
Income tax
Net income
-4.38%-127.17M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
Net income continuous Operations
-4.38%-127.17M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
Minority interest income
Net income attributable to the parent company
-4.38%-127.17M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-4.38%-127.17M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
Basic earnings per share
16.83%-1.68
19.15%-0.38
4.44%-0.43
14.81%-0.46
27.59%-0.42
17.21%-2.02
21.67%-0.47
28.57%-0.45
6.90%-0.54
7.94%-0.58
Diluted earnings per share
16.83%-1.68
19.15%-0.38
4.44%-0.43
14.81%-0.46
27.59%-0.42
17.21%-2.02
21.67%-0.47
28.57%-0.45
6.90%-0.54
7.94%-0.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 7M4M3M0000000
Operating revenue --7M--4M--3M--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 10.91%146.71M1.21%37.83M11.95%37.38M14.71%37.16M17.96%34.34M7.07%132.28M11.96%37.38M9.80%33.39M9.97%32.4M-3.87%29.12M
Selling and administrative expenses -0.57%28.72M-11.86%6.21M11.16%7.92M3.00%7.66M-4.77%6.93M-5.76%28.88M-6.24%7.05M-5.23%7.12M-8.82%7.43M-2.49%7.28M
-General and administrative expense -0.57%28.72M-11.86%6.21M11.16%7.92M3.00%7.66M-4.77%6.93M-5.76%28.88M-6.24%7.05M-5.23%7.12M-8.82%7.43M-2.49%7.28M
Research and development costs 14.12%118M4.25%31.62M12.17%29.46M18.20%29.51M25.53%27.41M11.31%103.39M17.25%30.33M14.73%26.26M17.16%24.97M-4.32%21.83M
Operating profit -5.62%-139.71M9.49%-33.83M-2.97%-34.38M-14.71%-37.16M-17.96%-34.34M-7.07%-132.28M-11.96%-37.38M-9.80%-33.39M-9.97%-32.4M3.87%-29.12M
Net non-operating interest income expense
Other net income (expense) 20.07%12.54M18.49%5.1M-24.20%2.11M23.23%2.42M108.45%2.91M28.92%10.45M-9.27%4.3M519.87%2.78M-5.75%1.97M69.74%1.4M
Other non- operating income (expenses) 20.07%12.54M18.49%5.1M-24.20%2.11M23.23%2.42M108.45%2.91M28.92%10.45M-9.27%4.3M519.87%2.78M-5.75%1.97M69.74%1.4M
Income before tax -4.38%-127.17M13.13%-28.73M-5.43%-32.27M-14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M
Income tax
Net income -4.38%-127.17M13.13%-28.73M-5.43%-32.27M-14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M
Net income continuous Operations -4.38%-127.17M13.13%-28.73M-5.43%-32.27M-14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M
Minority interest income
Net income attributable to the parent company -4.38%-127.17M13.13%-28.73M-5.43%-32.27M-14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -4.38%-127.17M13.13%-28.73M-5.43%-32.27M-14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M
Basic earnings per share 16.83%-1.6819.15%-0.384.44%-0.4314.81%-0.4627.59%-0.4217.21%-2.0221.67%-0.4728.57%-0.456.90%-0.547.94%-0.58
Diluted earnings per share 16.83%-1.6819.15%-0.384.44%-0.4314.81%-0.4627.59%-0.4217.21%-2.0221.67%-0.4728.57%-0.456.90%-0.547.94%-0.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Hanshow Technology
301275
+143.35%
Yong Jie New Material
603271
+124.42%
ZZT
873726
+29.99%
4
BEOKA
870199
+23.76%
5
Geovis Insighter Technology
920116
+21.91%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!